THC

Tenet Healthcare Corp. 10-Q Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended November 30, 1995, and the six-month period ended on that date. Tenet Healthcare Corporation operates a network of domestic general hospitals, rehabilitation facilities, and international healthcare businesses. The reporting period is significantly impacted by the March 1, 1995, acquisition of American Medical Holdings, Inc. (AMH), which doubled the number of hospitals in the system from 33 to 75.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net operating revenues increased 104% year-over-year for the six-month period, driven primarily by the inclusion of AMH facilities. Domestic general hospital revenues rose 134%.
• Profitability: Net income increased 174% to $301.1 million. This surge includes significant non-operating gains: $294.6 million in net gains on disposals of facilities and long-term investments (primarily the exchange of Hillhaven stock for Vencor stock and cash).
• Expense Structure: Operating expenses increased to $2,289.6 million. Salaries and benefits as a percentage of revenue improved to 39.4% from 42.7% due to cost control programs. However, the provision for doubtful accounts rose to 5.2% of revenue (from 3.6%) due to higher bad debt experience at acquired AMH facilities.
• Asset Disposals: The company sold international interests in Singapore, Australia, and Malaysia, and exchanged its Hillhaven investment, generating $402.8 million in proceeds from sales of facilities and assets.

Guidance, Outlook, and Risks

• Capital Expenditures: Management expects capital expenditures of approximately $385.0 million for the fiscal year ending May 31, 1996, and $400.0 million for each of the following two years, funded by operations and credit facilities.
• Liquidity: The company maintains $461.4 million in unused borrowing capacity under its revolving credit agreement. Management believes liquidity is adequate for short and long-term needs, including debt service and legal settlements.
• Regulatory Risks: The company faces potential adverse impacts from proposed Medicare legislation that could reduce payment rates. There is also pressure from managed care payors and potential changes to Medicaid reimbursement in certain states.
• Legal Contingencies: The company faces ongoing litigation related to its former psychiatric business. Reserves for these matters total approximately $39.7 million. Management does not believe unresolved proceedings will have a material adverse effect, though ultimate liability is uncertain.
• Debt Service: Interest expense increased significantly to $158.4 million for the six months due to debt incurred for the AMH acquisition and new senior notes issued in October 1995 ($500 million) and January 1996 ($320 million).

Investor Verification Checklist

• Non-Recurring Gains: Verify the sustainability of earnings by excluding the $294.6 million gain on asset disposals and affiliate sales from net income analysis.
• Bad Debt Trends: Monitor the "Provision for doubtful accounts," which rose to 5.2% of revenue, to assess the quality of receivables from newly acquired AMH hospitals.
• Debt Covenants: Review compliance with financial covenants (net worth, debt ratios, fixed-charge ratios) given the increased debt load from the AMH merger and new note issuances.
• Legal Reserves: Track the $39.7 million reserve for psychiatric litigation to ensure it remains sufficient against potential settlements.
• Medicare Policy: Assess the potential impact of pending federal legislation on Medicare reimbursement rates, which currently comprise 38.4% of patient revenues.